These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29177925)

  • 1. Genetics of pancreatic cancer and implications for therapy.
    Bhosale P; Cox V; Faria S; Javadi S; Viswanathan C; Koay E; Tamm E
    Abdom Radiol (NY); 2018 Feb; 43(2):404-414. PubMed ID: 29177925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
    Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
    Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetics of Pancreatic Neoplasms and Role of Screening.
    Katabathina VS; Rikhtehgar OY; Dasyam AK; Manickam R; Prasad SR
    Magn Reson Imaging Clin N Am; 2018 Aug; 26(3):375-389. PubMed ID: 30376976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial pancreatic cancer: from genes to improved patient care.
    Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of pancreatic cancer: potential clinical implications.
    Sakorafas GH; Tsiotos GG
    BioDrugs; 2001; 15(7):439-52. PubMed ID: 11520255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathogenesis of pancreatic cancer.
    Hansel DE; Kern SE; Hruban RH
    Annu Rev Genomics Hum Genet; 2003; 4():237-56. PubMed ID: 14527303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of pancreatic neuroendocrine tumors: implications for the clinic.
    Pea A; Hruban RH; Wood LD
    Expert Rev Gastroenterol Hepatol; 2015; 9(11):1407-19. PubMed ID: 26413978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and prevention of pancreatic cancer.
    Vimalachandran D; Ghaneh P; Costello E; Neoptolemos JP
    Cancer Control; 2004; 11(1):6-14. PubMed ID: 14749618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for pancreatic cancer in high-risk individuals: a call for endoscopic ultrasound.
    Larghi A; Verna EC; Lecca PG; Costamagna G
    Clin Cancer Res; 2009 Mar; 15(6):1907-14. PubMed ID: 19276278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges.
    Jiang Z; Zheng X; Li M; Liu M
    Front Med; 2023 Dec; 17(6):1135-1169. PubMed ID: 38151666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families.
    King E; Nehoray BM
    Clin J Oncol Nurs; 2019 Dec; 23(6):579-582. PubMed ID: 31730603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Pancreatic Cancer and Its Implications on Therapy.
    Tatarian T; Winter JM
    Surg Clin North Am; 2016 Dec; 96(6):1207-1221. PubMed ID: 27865273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of high-risk pancreatic cancer-prone families.
    Brand RE; Lynch HT
    Gastroenterol Clin North Am; 2004 Dec; 33(4):907-18. PubMed ID: 15528025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited pancreatic cancer: improvements in our understanding of genetics and screening.
    Rulyak SJ; Brentnall TA
    Int J Biochem Cell Biol; 2004 Aug; 36(8):1386-92. PubMed ID: 15147717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Repair Dysfunction in Pancreatic Cancer: A Clinically Relevant Subtype for Drug Development.
    Golan T; Javle M
    J Natl Compr Canc Netw; 2017 Aug; 15(8):1063-1069. PubMed ID: 28784866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of BRCA2 Mutation Status as Diagnostic, Predictive, and Prognosis Biomarker for Pancreatic Cancer.
    Martinez-Useros J; Garcia-Foncillas J
    Biomed Res Int; 2016; 2016():1869304. PubMed ID: 28078281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular technology and pancreatic cancer.
    Manu M; Buckels J; Bramhall S
    Br J Surg; 2000 Jul; 87(7):840-53. PubMed ID: 10931017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and screening of individuals at increased risk for pancreatic cancer with emphasis on known environmental and genetic factors and hereditary syndromes.
    Chu D; Kohlmann W; Adler DG
    JOP; 2010 May; 11(3):203-12. PubMed ID: 20442513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.